| 000 | 01816 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514195915.0 | ||
| 264 | 0 | _c20041027 | |
| 008 | 200410s 0 0 eng d | ||
| 022 | _a1461-1457 | ||
| 024 | 7 |
_a10.1017/S1461145704004365 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBech, Per | |
| 245 | 0 | 0 |
_aEscitalopram dose-response revisited: an alternative psychometric approach to evaluate clinical effects of escitalopram compared to citalopram and placebo in patients with major depression. _h[electronic resource] |
| 260 |
_bThe international journal of neuropsychopharmacology _cSep 2004 |
||
| 300 |
_a283-90 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAntidepressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCitalopram _xtherapeutic use |
| 650 | 0 | 4 |
_aDepressive Disorder, Major _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypnotics and Sedatives _xtherapeutic use |
| 650 | 0 | 4 | _aPsychiatric Status Rating Scales |
| 650 | 0 | 4 | _aPsychometrics |
| 650 | 0 | 4 |
_aPyridines _xtherapeutic use |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 |
_aSleep Initiation and Maintenance Disorders _xcomplications |
| 650 | 0 | 4 | _aStereoisomerism |
| 650 | 0 | 4 |
_aSuicide _xpsychology |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 | _aZolpidem |
| 700 | 1 | _aTanghøj, Per | |
| 700 | 1 | _aCialdella, Philippe | |
| 700 | 1 | _aAndersen, Henning Friis | |
| 700 | 1 | _aPedersen, Anders Gersel | |
| 773 | 0 |
_tThe international journal of neuropsychopharmacology _gvol. 7 _gno. 3 _gp. 283-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1017/S1461145704004365 _zAvailable from publisher's website |
| 999 |
_c15019106 _d15019106 |
||